Home Healthcare Biotechnology Non-invasive Cancer Diagnostics Market

Non-invasive Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Pathology-based Instruments, Imaging Instruments, Kits & Reagents, Consumables), By Technology (Imaging, Liquid Biopsy, Immunoassay), By Indication (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Blood Cancer, Liver Cancer, Cervical Cancer, Skin Cancer, Others), By End Use (Hospitals, Diagnostic Laboratories, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 20, 2026 | Author: Dhanashri B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Non-invasive Cancer Diagnostics Market, By Product 2022-2034 (USD MILLION/ Units)
    1. Instruments
    2. Pathology-based Instruments
      1. PCR Instruments
      2. NGS Instruments
      3. Microarrays
    3. Imaging Instruments
      1. Magnetic Resonance Imaging
      2. Computed Tomography
      3. Mammography
      4. Others
    4. Kits & Reagents
    5. Consumables
  2. Non-invasive Cancer Diagnostics Market, By Technology 2022-2034 (USD MILLION/ Units)
    1. Imaging
    2. Liquid Biopsy
    3. Immunoassay
  3. Non-invasive Cancer Diagnostics Market, By Indication 2022-2034 (USD MILLION/ Units)
    1. Lung Cancer
    2. Breast Cancer
    3. Colorectal Cancer
    4. Prostate Cancer
    5. Blood Cancer
    6. Liver Cancer
    7. Cervical Cancer
    8. Skin Cancer
    9. Others
  4. Non-invasive Cancer Diagnostics Market, By End Use 2022-2034 (USD MILLION/ Units)
    1. Hospitals
    2. Diagnostic Laboratories
    3. Others
  5. Regional Non-invasive Cancer Diagnostics Market
    1. North America
      1. North America Non-invasive Cancer Diagnostics Market By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
      2. North America Non-invasive Cancer Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Imaging
        2. Liquid Biopsy
        3. Immunoassay
      3. North America Non-invasive Cancer Diagnostics Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Blood Cancer
        6. Liver Cancer
        7. Cervical Cancer
        8. Skin Cancer
        9. Others
      4. North America Non-invasive Cancer Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
      5. U.S.
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
        6. Imaging
        7. Liquid Biopsy
        8. Immunoassay
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Prostate Cancer
        13. Blood Cancer
        14. Liver Cancer
        15. Cervical Cancer
        16. Skin Cancer
        17. Others
        18. Hospitals
        19. Diagnostic Laboratories
        20. Others
      6. Canada
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
        6. Imaging
        7. Liquid Biopsy
        8. Immunoassay
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Prostate Cancer
        13. Blood Cancer
        14. Liver Cancer
        15. Cervical Cancer
        16. Skin Cancer
        17. Others
        18. Hospitals
        19. Diagnostic Laboratories
        20. Others
    2. Europe
      1. Europe Non-invasive Cancer Diagnostics Market By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
      2. Europe Non-invasive Cancer Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Imaging
        2. Liquid Biopsy
        3. Immunoassay
      3. Europe Non-invasive Cancer Diagnostics Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Blood Cancer
        6. Liver Cancer
        7. Cervical Cancer
        8. Skin Cancer
        9. Others
      4. Europe Non-invasive Cancer Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
      5. U.K.
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
        6. Imaging
        7. Liquid Biopsy
        8. Immunoassay
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Prostate Cancer
        13. Blood Cancer
        14. Liver Cancer
        15. Cervical Cancer
        16. Skin Cancer
        17. Others
        18. Hospitals
        19. Diagnostic Laboratories
        20. Others
      6. Germany
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
        6. Imaging
        7. Liquid Biopsy
        8. Immunoassay
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Prostate Cancer
        13. Blood Cancer
        14. Liver Cancer
        15. Cervical Cancer
        16. Skin Cancer
        17. Others
        18. Hospitals
        19. Diagnostic Laboratories
        20. Others
      7. France
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
        6. Imaging
        7. Liquid Biopsy
        8. Immunoassay
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Prostate Cancer
        13. Blood Cancer
        14. Liver Cancer
        15. Cervical Cancer
        16. Skin Cancer
        17. Others
        18. Hospitals
        19. Diagnostic Laboratories
        20. Others
      8. Spain
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
        6. Imaging
        7. Liquid Biopsy
        8. Immunoassay
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Prostate Cancer
        13. Blood Cancer
        14. Liver Cancer
        15. Cervical Cancer
        16. Skin Cancer
        17. Others
        18. Hospitals
        19. Diagnostic Laboratories
        20. Others
      9. Italy
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
        6. Imaging
        7. Liquid Biopsy
        8. Immunoassay
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Prostate Cancer
        13. Blood Cancer
        14. Liver Cancer
        15. Cervical Cancer
        16. Skin Cancer
        17. Others
        18. Hospitals
        19. Diagnostic Laboratories
        20. Others
      10. Russia
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
        6. Imaging
        7. Liquid Biopsy
        8. Immunoassay
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Prostate Cancer
        13. Blood Cancer
        14. Liver Cancer
        15. Cervical Cancer
        16. Skin Cancer
        17. Others
        18. Hospitals
        19. Diagnostic Laboratories
        20. Others
      11. Nordic
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
        6. Imaging
        7. Liquid Biopsy
        8. Immunoassay
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Prostate Cancer
        13. Blood Cancer
        14. Liver Cancer
        15. Cervical Cancer
        16. Skin Cancer
        17. Others
        18. Hospitals
        19. Diagnostic Laboratories
        20. Others
      12. Benelux
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
        6. Imaging
        7. Liquid Biopsy
        8. Immunoassay
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Prostate Cancer
        13. Blood Cancer
        14. Liver Cancer
        15. Cervical Cancer
        16. Skin Cancer
        17. Others
        18. Hospitals
        19. Diagnostic Laboratories
        20. Others
      13. Rest of Europe
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
        6. Imaging
        7. Liquid Biopsy
        8. Immunoassay
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Prostate Cancer
        13. Blood Cancer
        14. Liver Cancer
        15. Cervical Cancer
        16. Skin Cancer
        17. Others
        18. Hospitals
        19. Diagnostic Laboratories
        20. Others
    3. APAC
      1. APAC Non-invasive Cancer Diagnostics Market By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
      2. APAC Non-invasive Cancer Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Imaging
        2. Liquid Biopsy
        3. Immunoassay
      3. APAC Non-invasive Cancer Diagnostics Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Blood Cancer
        6. Liver Cancer
        7. Cervical Cancer
        8. Skin Cancer
        9. Others
      4. APAC Non-invasive Cancer Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
      5. China
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
        6. Imaging
        7. Liquid Biopsy
        8. Immunoassay
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Prostate Cancer
        13. Blood Cancer
        14. Liver Cancer
        15. Cervical Cancer
        16. Skin Cancer
        17. Others
        18. Hospitals
        19. Diagnostic Laboratories
        20. Others
      6. Korea
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
        6. Imaging
        7. Liquid Biopsy
        8. Immunoassay
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Prostate Cancer
        13. Blood Cancer
        14. Liver Cancer
        15. Cervical Cancer
        16. Skin Cancer
        17. Others
        18. Hospitals
        19. Diagnostic Laboratories
        20. Others
      7. Japan
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
        6. Imaging
        7. Liquid Biopsy
        8. Immunoassay
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Prostate Cancer
        13. Blood Cancer
        14. Liver Cancer
        15. Cervical Cancer
        16. Skin Cancer
        17. Others
        18. Hospitals
        19. Diagnostic Laboratories
        20. Others
      8. India
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
        6. Imaging
        7. Liquid Biopsy
        8. Immunoassay
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Prostate Cancer
        13. Blood Cancer
        14. Liver Cancer
        15. Cervical Cancer
        16. Skin Cancer
        17. Others
        18. Hospitals
        19. Diagnostic Laboratories
        20. Others
      9. Australia
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
        6. Imaging
        7. Liquid Biopsy
        8. Immunoassay
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Prostate Cancer
        13. Blood Cancer
        14. Liver Cancer
        15. Cervical Cancer
        16. Skin Cancer
        17. Others
        18. Hospitals
        19. Diagnostic Laboratories
        20. Others
      10. Taiwan
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
        6. Imaging
        7. Liquid Biopsy
        8. Immunoassay
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Prostate Cancer
        13. Blood Cancer
        14. Liver Cancer
        15. Cervical Cancer
        16. Skin Cancer
        17. Others
        18. Hospitals
        19. Diagnostic Laboratories
        20. Others
      11. South East Asia
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
        6. Imaging
        7. Liquid Biopsy
        8. Immunoassay
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Prostate Cancer
        13. Blood Cancer
        14. Liver Cancer
        15. Cervical Cancer
        16. Skin Cancer
        17. Others
        18. Hospitals
        19. Diagnostic Laboratories
        20. Others
      12. Rest of Asia-Pacific
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
        6. Imaging
        7. Liquid Biopsy
        8. Immunoassay
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Prostate Cancer
        13. Blood Cancer
        14. Liver Cancer
        15. Cervical Cancer
        16. Skin Cancer
        17. Others
        18. Hospitals
        19. Diagnostic Laboratories
        20. Others
    4. Middle East and Africa
      1. Middle East and Africa Non-invasive Cancer Diagnostics Market By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
      2. Middle East and Africa Non-invasive Cancer Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Imaging
        2. Liquid Biopsy
        3. Immunoassay
      3. Middle East and Africa Non-invasive Cancer Diagnostics Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Blood Cancer
        6. Liver Cancer
        7. Cervical Cancer
        8. Skin Cancer
        9. Others
      4. Middle East and Africa Non-invasive Cancer Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
      5. UAE
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
        6. Imaging
        7. Liquid Biopsy
        8. Immunoassay
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Prostate Cancer
        13. Blood Cancer
        14. Liver Cancer
        15. Cervical Cancer
        16. Skin Cancer
        17. Others
        18. Hospitals
        19. Diagnostic Laboratories
        20. Others
      6. Turkey
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
        6. Imaging
        7. Liquid Biopsy
        8. Immunoassay
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Prostate Cancer
        13. Blood Cancer
        14. Liver Cancer
        15. Cervical Cancer
        16. Skin Cancer
        17. Others
        18. Hospitals
        19. Diagnostic Laboratories
        20. Others
      7. Saudi Arabia
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
        6. Imaging
        7. Liquid Biopsy
        8. Immunoassay
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Prostate Cancer
        13. Blood Cancer
        14. Liver Cancer
        15. Cervical Cancer
        16. Skin Cancer
        17. Others
        18. Hospitals
        19. Diagnostic Laboratories
        20. Others
      8. South Africa
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
        6. Imaging
        7. Liquid Biopsy
        8. Immunoassay
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Prostate Cancer
        13. Blood Cancer
        14. Liver Cancer
        15. Cervical Cancer
        16. Skin Cancer
        17. Others
        18. Hospitals
        19. Diagnostic Laboratories
        20. Others
      9. Egypt
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
        6. Imaging
        7. Liquid Biopsy
        8. Immunoassay
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Prostate Cancer
        13. Blood Cancer
        14. Liver Cancer
        15. Cervical Cancer
        16. Skin Cancer
        17. Others
        18. Hospitals
        19. Diagnostic Laboratories
        20. Others
      10. Nigeria
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
        6. Imaging
        7. Liquid Biopsy
        8. Immunoassay
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Prostate Cancer
        13. Blood Cancer
        14. Liver Cancer
        15. Cervical Cancer
        16. Skin Cancer
        17. Others
        18. Hospitals
        19. Diagnostic Laboratories
        20. Others
      11. Rest of MEA
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
        6. Imaging
        7. Liquid Biopsy
        8. Immunoassay
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Prostate Cancer
        13. Blood Cancer
        14. Liver Cancer
        15. Cervical Cancer
        16. Skin Cancer
        17. Others
        18. Hospitals
        19. Diagnostic Laboratories
        20. Others
    5. LATAM
      1. LATAM Non-invasive Cancer Diagnostics Market By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
      2. LATAM Non-invasive Cancer Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Imaging
        2. Liquid Biopsy
        3. Immunoassay
      3. LATAM Non-invasive Cancer Diagnostics Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Blood Cancer
        6. Liver Cancer
        7. Cervical Cancer
        8. Skin Cancer
        9. Others
      4. LATAM Non-invasive Cancer Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
      5. Brazil
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
        6. Imaging
        7. Liquid Biopsy
        8. Immunoassay
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Prostate Cancer
        13. Blood Cancer
        14. Liver Cancer
        15. Cervical Cancer
        16. Skin Cancer
        17. Others
        18. Hospitals
        19. Diagnostic Laboratories
        20. Others
      6. Mexico
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
        6. Imaging
        7. Liquid Biopsy
        8. Immunoassay
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Prostate Cancer
        13. Blood Cancer
        14. Liver Cancer
        15. Cervical Cancer
        16. Skin Cancer
        17. Others
        18. Hospitals
        19. Diagnostic Laboratories
        20. Others
      7. Argentina
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
        6. Imaging
        7. Liquid Biopsy
        8. Immunoassay
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Prostate Cancer
        13. Blood Cancer
        14. Liver Cancer
        15. Cervical Cancer
        16. Skin Cancer
        17. Others
        18. Hospitals
        19. Diagnostic Laboratories
        20. Others
      8. Chile
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
        6. Imaging
        7. Liquid Biopsy
        8. Immunoassay
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Prostate Cancer
        13. Blood Cancer
        14. Liver Cancer
        15. Cervical Cancer
        16. Skin Cancer
        17. Others
        18. Hospitals
        19. Diagnostic Laboratories
        20. Others
      9. Colombia
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
        6. Imaging
        7. Liquid Biopsy
        8. Immunoassay
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Prostate Cancer
        13. Blood Cancer
        14. Liver Cancer
        15. Cervical Cancer
        16. Skin Cancer
        17. Others
        18. Hospitals
        19. Diagnostic Laboratories
        20. Others
      10. Rest of LATAM
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
        6. Imaging
        7. Liquid Biopsy
        8. Immunoassay
        9. Lung Cancer
        10. Breast Cancer
        11. Colorectal Cancer
        12. Prostate Cancer
        13. Blood Cancer
        14. Liver Cancer
        15. Cervical Cancer
        16. Skin Cancer
        17. Others
        18. Hospitals
        19. Diagnostic Laboratories
        20. Others
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.